Advertisement

Topics

AstraZeneca, Merck get expanded approval for Lynparza

06:21 EDT 18 Aug 2017 | SmartBrief

AstraZeneca and Merck received approval from the FDA to expand the indication for Lynparza, or olaparib, to cover use as a ma -More

Original Article: AstraZeneca, Merck get expanded approval for Lynparza

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca, Merck get expanded approval for Lynparza"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...